Diet has been identified as a major risk factor for colon cancer in younger adults, particularly those involving red and processed meats
Read Full Article
#coloncancer #diet #health #meat #youngadults
Read Full Article
#coloncancer #diet #health #meat #youngadults
www.lerner.ccf.org
Diet revealed as a main risk factor for colon cancer in younger adults
AI analyses suggest it may be more impactful to address diet for colon cancer prevention in younger adults, especially when it comes to red meat.
👍2
New Technology to Revert Cancer Cells to Normal Cells. Groundbreaking technology can treat colon cancer by converting cancer cells into a state resembling normal colon cells without killing them, thus avoiding side effects.
Read Full Article
#CancerResearch #InnovativeTreatment #ColonCancer #HealthTech #BreakthroughScience
Read Full Article
#CancerResearch #InnovativeTreatment #ColonCancer #HealthTech #BreakthroughScience
news.kaist.ac.kr
KAIST Develops Foundational Technology to Revert Cancer Cells to Normal Cells
Despite the development of numerous cancer treatment technologies, the common goal of current cancer...
👍2👏2❤1🔥1
New Technology to Revert Cancer Cells to Normal Cells. Groundbreaking technology can treat colon cancer by converting cancer cells into a state resembling normal colon cells without killing them, thus avoiding side effects. This study was done in mice.
Read Full Article
#NewTechnology #CancerResearch #ColonCancer #MedicalBreakthrough #HealthInnovation
Read Full Article
#NewTechnology #CancerResearch #ColonCancer #MedicalBreakthrough #HealthInnovation
news.kaist.ac.kr
News at KAIST
사이트 설명을 간략히 기록 해주세요.
Exercise boosts survival rates in colon cancer patients, study shows | Structured Exercise after Adjuvant Chemotherapy for Colon Cancer 💪🎗️📊
Read Full Article
#ColonCancer #ExerciseBenefits #SurvivalRates #HealthResearch #AdjuvantChemotherapy
Read Full Article
#ColonCancer #ExerciseBenefits #SurvivalRates #HealthResearch #AdjuvantChemotherapy
AP News
Exercise boosts survival rates in colon cancer patients, study shows
A first-of-its-kind experiment shows a three-year exercise program improved survival in colon cancer patients.
Exercise ‘better than drugs’ 💊 to stop cancer returning after treatment, trial finds. First clear evidence structured exercise 🏋️♂️ reduces risk of dying by a third, stop tumours coming back or new cancer developing. Colon cancer patients on exercise regime after treatment had 37% lower risk of death. 🏥💪
Read Full Article
#ExerciseForHealth #CancerPrevention #HealthyLifestyle #ColonCancer #WellnessWarrior
Read Full Article
#ExerciseForHealth #CancerPrevention #HealthyLifestyle #ColonCancer #WellnessWarrior
the Guardian
Exercise ‘better than drugs’ to stop cancer returning after treatment, trial finds
First clear evidence that structured exercise regime reduces risk of dying by a third, can stop tumours coming back or a new cancer developing
🔥1🤔1
A close look at colibactin, a microbial toxin linked to colon cancer, shows how it reacts with and damages DNA 🦠💔🧬
Read Full Article
#colibactin #microbialtoxins #coloncancer #DNAdamage #healthresearch
Read Full Article
#colibactin #microbialtoxins #coloncancer #DNAdamage #healthresearch
Science News
How a bacterial toxin linked to colon cancer messes with DNA
A closeup look at colibactin’s structure reveals chemical motifs that guide its mutation-wreaking “warheads” to specific stretches of DNA.
😨1
Colon cancer now leading cause of cancer deaths under 50 in US
Read Full Article
#ColonCancer #CancerAwareness #HealthNews
Read Full Article
#ColonCancer #CancerAwareness #HealthNews
the Guardian
Colon cancer now leading cause of cancer deaths under 50 in US
Experts warn younger people not to dismiss symptoms such as rectal bleeding as diagnoses rise for those under 50
😨2
Science News
The number of young people getting diagnosed with colon cancer is going up – while rates for people over 60 are declining. Some adults in the US who are under 45 and experiencing worrying symptoms are struggling to get insurance coverage for colonoscopies…
* 🩺 Young adults (20s-30s) facing rising colon cancer rates are encountering difficulties getting insurance coverage for colonoscopies, which are considered diagnostic tests and not fully covered like preventive screenings under the ACA for those under 45.
* 💸 A 35-year-old experienced a diagnostic colonoscopy denied by insurance, costing him $2,000 out-of-pocket, despite symptoms like bowel changes and weight loss, highlighting the financial and emotional strain.
* 🔬 While the recommended colon cancer screening age was recently lowered to 45, the increasing rates in younger demographics prompt ongoing discussions about further age reductions and the need for research into potential causes, such as environmental exposures.
#ColonCancer #HealthInsurance #PreventiveCare
(⚠️ Formatting disabled due to Markdown error)
* 💸 A 35-year-old experienced a diagnostic colonoscopy denied by insurance, costing him $2,000 out-of-pocket, despite symptoms like bowel changes and weight loss, highlighting the financial and emotional strain.
* 🔬 While the recommended colon cancer screening age was recently lowered to 45, the increasing rates in younger demographics prompt ongoing discussions about further age reductions and the need for research into potential causes, such as environmental exposures.
#ColonCancer #HealthInsurance #PreventiveCare
(⚠️ Formatting disabled due to Markdown error)
Adding immunotherapy to chemotherapy for stage III colon cancer (dMMR) cuts the risk of recurrence or death by 50%. A landmark phase III trial finds that 86% of patients remained disease-free after 3 years, establishing a new global "standard of care" for this specific genetic subtype.
Read Full Article
#Immunotherapy #ColonCancer #dMMR
Read Full Article
#Immunotherapy #ColonCancer #dMMR
The New England Journal of Medicine
Atezolizumab plus FOLFOX for Stage III Mismatch Repair–Deficient Colon Cancer | NEJM
Standard adjuvant chemotherapy for stage III colon cancer consists of a fluoropyrimidine-plus-oxaliplatin
regimen. Whether the addition of atezolizumab (an anti–programmed death ligand 1 agent)
to ...
regimen. Whether the addition of atezolizumab (an anti–programmed death ligand 1 agent)
to ...
Colon cancer’s invisibility cloak removed by eliminating a single gene - a fundamental breakthrough. The result was 100% eradication of tumours when paired with immunotherapy treatment in mouse models.
Read Full Article
#ColonCancer #ImmunotherapyBreakthrough #CancerResearch
Read Full Article
#ColonCancer #ImmunotherapyBreakthrough #CancerResearch
University of Calgary
UCalgary study tears off colon cancer’s invisibility cloak
Research shows removing a single gene makes cancerous cells a target for immunotherapy
❤3👏1